ACET 内幕交易
ACET 的 SEC Form 4 内幕交易记录
总交易
32
买入
3
买入总额
$1.6M
卖出总额
$1.9M
| 信号 | 内幕人 | 职位 | 方向 | 股数 | 价格 | 金额 | 日期 | 信号原因 |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(37) | ORBIMED ADVISORS LLC | - | 卖出 | 32,523 | $6.29 | $205K | 2026-04-08 | 大股东(>10%)卖出, 非10b5-1计划卖出 |
| ★★★★★(37) | ORBIMED ADVISORS LLC | - | 卖出 | 40,416 | $6.52 | $264K | 2026-04-08 | 大股东(>10%)卖出, 非10b5-1计划卖出 |
| ★★★★★(30) | RA CAPITAL MANAGEMENT, L.P. | - | 买入 | 74,751 | $7.27 | $543K | 2026-02-20 | 大股东(>10%)买入, 大额买入(>$500K) |
| ★★★★★(30) | RA CAPITAL MANAGEMENT, L.P. | - | 买入 | 74,268 | $7.21 | $535K | 2026-02-19 | 大股东(>10%)买入, 大额买入(>$500K) |
| ★★★★★(30) | RA CAPITAL MANAGEMENT, L.P. | - | 买入 | 74,577 | $7.04 | $525K | 2026-02-18 | 大股东(>10%)买入, 大额买入(>$500K) |
| ★★★★★(30) | ORBIMED ADVISORS LLC | - | 卖出 | 29,319 | $6.53 | $191K | 2026-04-07 | 大股东(>10%)卖出, 非10b5-1计划卖出 |
| ★★★★★(25) | ORBIMED ADVISORS LLC | - | 卖出 | 78,499 | $6.55 | $514K | 2026-04-09 | 董事卖出, 大额卖出(>$500K) |
| ★★★★★(22) | ORBIMED ADVISORS LLC | - | 卖出 | 2,400 | $6.38 | $15K | 2026-04-07 | 大股东(>10%)卖出, 非10b5-1计划卖出 |
| ★★★★★(22) | ORBIMED ISRAEL GP LTD. | - | 卖出 | 64,242 | $6.43 | $413K | 2026-04-07 | 大股东(>10%)卖出, 非10b5-1计划卖出 |
| ★★★★★(10) | ORBIMED ADVISORS ISRAEL II LTD | - | 卖出 | 40,416 | $6.55 | $265K | 2026-04-08 | 非10b5-1计划卖出 |
| ★★★★★(0) | KLICKSTEIN LLOYD | Chief Medical Officer | 卖出 | 18,300 | - | - | 2026-08-05 | |
| ★★★★★(0) | KLICKSTEIN LLOYD | - | 卖出 | 4,200 | - | - | 2026-06-21 | |
| ★★★★★(0) | CHODAKEWITZ JEFFREY | - | 卖出 | 4,200 | - | - | 2026-06-21 | |
| ★★★★★(0) | GRISSINGER MICHAEL | - | 卖出 | 4,200 | - | - | 2026-06-21 | |
| ★★★★★(0) | PENG KATIE | - | 卖出 | 4,200 | - | - | 2026-06-21 | |
| ★★★★★(0) | SINCLAIR ANDREW | - | 卖出 | 4,200 | - | - | 2026-06-21 | |
| ★★★★★(0) | DUBIN STEVE | - | 卖出 | 4,200 | - | - | 2026-06-21 | |
| ★★★★★(0) | AFTAB BLAKE | Chief Scientific Officer | 卖出 | 55,000 | - | - | 2026-06-19 | |
| ★★★★★(0) | SCHOR CHEN | President & CEO | 卖出 | 55,000 | - | - | 2026-06-19 | |
| ★★★★★(0) | RA CAPITAL MANAGEMENT, L.P. | - | 卖出 | 250,000 | - | - | 2026-04-27 | |
| ★★★★★(0) | RA CAPITAL MANAGEMENT, L.P. | - | 卖出 | 0 | - | - | 2026-02-17 | |
| ★★★★★(0) | ORBIMED ADVISORS LLC | - | 卖出 | 0 | - | - | 2026-04-07 | |
| ★★★★★(0) | SCHOR CHEN | President & CEO | 卖出 | 468,555 | - | - | 2026-03-25 | |
| ★★★★★(0) | HARVEY BRIAN NICHOLAS | Chief Financial Officer | 卖出 | 43,361 | - | - | 2026-03-25 | |
| ★★★★★(0) | HEALEY DON | Chief Technology Officer | 卖出 | 43,361 | - | - | 2026-03-25 | |
| ★★★★★(0) | MALTZMAN JULIA D. | Chief Medical Officer | 卖出 | 72,555 | - | - | 2026-03-25 | |
| ★★★★★(0) | AFTAB BLAKE | Chief Scientific Officer | 卖出 | 72,555 | - | - | 2026-03-25 | |
| ★★★★★(0) | HARVEY BRIAN NICHOLAS | Chief Financial Officer | 卖出 | 546 | $8.44 | $5K | 2026-01-24 | |
| ★★★★★(0) | AFTAB BLAKE | Chief Scientific Officer | 卖出 | 535 | $8.44 | $5K | 2026-01-24 | |
| ★★★★★(0) | SCHOR CHEN | President & CEO | 卖出 | 1,755 | $8.44 | $15K | 2026-01-24 | |
| ★★★★★(0) | SCHOR CHEN | President & CEO | 卖出 | 0 | - | - | 2026-01-24 | |
| ★★★★★(0) | HEALEY DON | Chief Technology Officer | 卖出 | 535 | $8.44 | $5K | 2026-01-24 |